Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.

A new avenue for targeted drug delivery has been proposed by researchers from The Grainger College of Engineering at the ...

For clinical questions that were not addressed by the AABB and the International Collaboration for Transfusion Medicine Guidelines (the use of leukoreduction and platelet transfusion in solid tumors ...

Saint Francis Hospital is partnering with the Our Blood Institute to hosts the first mobile platelet drive in northeast ...

The data may change how patients are treated following a diagnosis for advanced triple-negative breast cancer, one expert ...

Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, ...

In vivo platelet activation and related pathways may be linked to small airways disease and pulmonary vascular changes in smokers.

Amgen Inc. (NASDAQ: AMGN )’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for ...

A new method for targeted drug delivery uses chemically tagged platelets, offering fast, efficient treatment with minimal long-term drug presence.

We're about a week and a half away from Father's Day, and one local daughter has given her dad the greatest gift he could ...